Fundamental Analysis
50 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +12.1% | +16.9% | 3 / 3 | +17.6% | -4.73 pp | -0.90 pp | +31.8% | 0.85 | 11.30 | 5.616 | +17,6% | 1.011 | +12,0% | 11.30 | 15.65 | −27,8% |
| Pts | 0 | 0 | 12 | 8 | 0 | 4 | 12 | 6 | 12 | |||||||
Valuation annotation:Price: 55.800 (close price on 2026-10-19)EPS (TTM): 4.936
Financial charts
1.Revenue & growth
VND bn5.616Q2/26
1.Revenue & growth
VND bn5.616Q2/26
2.Profit & growth
VND bn991Q2/26
3.Profit mix (Penman)
VND bn4.660Q2/26
4.Margins & cost structure
%48.0%Q2/26
5.Returns & cash cycle
% · days49.6%Q2/26
6.Earnings quality & cash
VND bn2.126Q2/26
7.Asset structure
VND bn31.012Q2/26
8.Funding & debt health
VND bn · times31.012Q2/26
9.Revenue backlog
VND bn2.133Q2/26
10.Valuation
times · %11,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.342Q2/26
Adjusted EPS growth, latest quarter
12.1%
Average adjusted EPS growth, 3 quarters
16.9%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26